News Detail

SL Bio, Horizon Space Acquisition II close business combination, to list as SL Science on Nasdaq

PUBT · 1d ago

Listen to the news

SL Bio, Horizon Space Acquisition II close business combination, to list as SL Science on Nasdaq

SL Bio closed its business combination with Horizon Space Acquisition II, creating Cayman Islands holding company SL Science Holding.
SL Science ordinary shares expected to begin trading on Nasdaq Global Market on June 15 under ticker SLBT.
Deal implied SL Bio equity valuation of about USD 5.57 billion; transaction included a concurrent USD 7.8 million PIPE financing.
Proceeds aimed at advancing gamma delta T cell “off-the-shelf” therapies for solid tumors, with planned trials in pancreatic and brain cancers.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Horizon Space Acquisition II Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606121451PRIMZONEFULLFEED9746352) on June 12, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.

What's Trending

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.